INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 495
10/02/2017
Comentaris i suggeriments
Banner-noves-convocatories-02
Cercador de convocatòries
Projectes
Termini exhaurit
EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
There is a global challenge to recruit and train the next generation of clinical investigators, not least in endocrinology/diabetes. The major goal of this Mentorship Programme will be to identify and promote the advancement of the next generation of leading clinical diabetologists in Europe. Through its various activities the Programme will help award recipients (“Mentees”) develop into leaders by refining their skills in the three cardinal areas of clinical diabetes, research and communication, thereby keeping them in the field of diabetes and facilitating their appointment to senior academic positions at major European institutions.
 
Termini exhaurit
EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
EFSD has established this independent research programme called the EFSD/Boehringer Ingelheim European Research Programme in Microvascular Complications of Diabetes to encourage new products aimed at advancing current knowledge in this domain through innovative basic or clinical research.
This EFSD/Boehringer Ingelheim European Diabetes Research Programme is intended to stimulate and accelerate European basic and clinical research in the specific area of microvascular complications (retinopathy, nephropathy and neuropathy) of diabetes. Proposals dealing with the following are especially but not exclusively welcome: investigations of various cell types in the eye and kidney and their role and interaction during the course of development of diabetic retinopathy and diabetic nephropathy.
 
Termini exhaurit
EUROPEAN SOCIETY OF INTENSIVE CARE MEDICINE
The European Society of Intensive Care Medicine is an Association of individual persons. It supports and promotes the advancement of knowledge in intensive care medicine, in particular the promotion of the highest standards of multidisciplinary care of critically ill patients and their families through education, research and professional development.

In order to foster progression of women in academic careers, this prize supports the development of research activities undertaken with the active contribution of a female applicant. The specific intent is to provide support for young and talented female physicians/scientists who have the potential to become outstanding independent investigators in the field of intensive care and emergency medicine.

The research proposal may focus on approaches in topics ranging from basic cellular responses to outcome research, and may include clinical applications as well as translational science.
 
Termini exhaurit
EUROPEAN SOCIETY OF INTENSIVE CARE MEDICINE
The European Society of Intensive Care Medicine is an Association of individual persons. It supports and promotes the advancement of knowledge in intensive care medicine, in particular the promotion of the highest standards of multidisciplinary care of critically ill patients and their families through education, research and professional development.

The Basic Science Award supports a research project to be performed by an investigator in a research laboratory. Approaches may vary topically from basic cellular and molecular physiology, cell biology, molecular biology and genetics to animal physiology and translational science.
 
Termini exhaurit
EUROPEAN SOCIETY OF INTENSIVE CARE MEDICINE
The European Society of Intensive Care Medicine is an Association of individual persons. It supports and promotes the advancement of knowledge in intensive care medicine, in particular the promotion of the highest standards of multidisciplinary care of critically ill patients and their families through education, research and professional development.

The Clinical Research Award supports a research project to be performed by an investigator in a clinical environment. Some aspects of the proposal may involve collaboration with research laboratories. However, applications that lack a clinical component will not be considered.

Proposals may be based on approaches ranging from physiology, diagnostic procedures, therapeutic interventions, to epidemiologic studies and evaluation of practices.
 
Termini exhaurit
EUROPEAN SOCIETY OF INTENSIVE CARE MEDICINE
The European Society of Intensive Care Medicine is an Association of individual persons. It supports and promotes the advancement of knowledge in intensive care medicine, in particular the promotion of the highest standards of multidisciplinary care of critically ill patients and their families through education, research and professional development.

The ESICM Established Investigator Award will support the research activities of a senior physician/scientist active in clinical or basic research. The specific intent is to provide support for investigators who have already established their independent research program in the field of intensive care and emergency medicine, and who can demonstrate a commitment to facilitate research training of young colleagues.

The research proposal may rely on approaches on topics ranging from basic cellular responses to outcome research, and may include clinical applications as well as translational science.
 
Termini exhaurit
EUROPEAN SOCIETY OF INTENSIVE CARE MEDICINE
The European Society of Intensive Care Medicine is an Association of individual persons. It supports and promotes the advancement of knowledge in intensive care medicine, in particular the promotion of the highest standards of multidisciplinary care of critically ill patients and their families through education, research and professional development.

The ESICM Young Investigator Award supports the development of research activities undertaken with the active contribution of the applicant. The specific intent is to provide support for young and talented physicians/scientists that have the potential to become outstanding independent investigators in the field of intensive care and emergency medicine.

Research proposals may rely on approaches ranging from basic cellular responses to outcome research, and may include clinical applications as well as translational science.
 
Termini exhaurit
EUROPEAN SOCIETY OF INTENSIVE CARE MEDICINE
The European Society of Intensive Care Medicine is an Association of individual persons. It supports and promotes the advancement of knowledge in intensive care medicine, in particular the promotion of the highest standards of multidisciplinary care of critically ill patients and their families through education, research and professional development.

The NEXT Start-Up Grant supports the professional development of talented newly board-certified intensivists who have already a background in research and are willing to develop independent research programmes. The specific intent is to provide support for young and talented researchers/scientists who have the potential to become established independent investigators in the field of intensive care and emergency medicine.

Research programme proposals may rely on approaches ranging from basic cellular responses to outcome research, and may include clinical applications as well as translational science.
 
Termini exhaurit
FARA - FRIEDREICH'S ATAXIA RESEARCH ALLIANCE
FARA supports research through funding competitive grants, promoting collaboration among scientists, advocating for public-private partnerships that support drug discovery, drug development and clinical research and hosting open forums for leading scientists to share their insights, ideas and challenges to advancing treatments for FA.
 
Termini exhaurit
FRAXA RESEARCH FOUNDATION
FRAXA is a nonprofit, tax-exempt organization based the US. Solely committed to finding a cure for fragile X, FRAXA has funded more than $25 million in biomedical research, yielding discoveries that are changing the lives of families coping with fragile X. FRAXA is one of the most efficient and effective charities in the world, with management and general expenses under 4 percent and research expenditures at 86 percent.
 
Termini exhaurit
FRAXA RESEARCH FOUNDATION
FRAXA is a nonprofit, tax-exempt organization based the US. Solely committed to finding a cure for fragile X, FRAXA has funded more than $25 million in biomedical research, yielding discoveries that are changing the lives of families coping with fragile X. FRAXA is one of the most efficient and effective charities in the world, with management and general expenses under 4 percent and research expenditures at 86 percent.
 
Termini exhaurit
PROSTATE CANCER FOUNDATION
The Prostate Cancer Foundation (PCF) is pleased to announce a Request for Applications for PCF Challenge Awards for investigations of metastatic, lethal prostate cancer. These awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired.
 
Termini exhaurit
FUNDACIO LA CAIXA
L'objecte de la present convocatòria és la tutoria de projectes de valorització dels actius resultants de la investigació, per al seu trasllat al mercat, ja sigui com un spin-off o com un acord de transferència, que requereixen la validació i desenvolupament de la seva proposta de generació de valor.
Més específicament, el programa donarà suport a projectes de les àrees de la Vida, Medicina i Ciències de la Salut proposades pels centres, basats en actius per als quals s'ha sol·licitat o serà sol·licitada una patent o model d'utilitat, i destinats a afegir valor per a la seva transferència al mercat.
Dins les àrees de la Vida, Medicina i Ciències de la Salut, es tindran en compte els projectes dels següents camps:
  • Ciències de la Vida: Biomatemàtica, Biologia Cel·lular, Biologia Humana, Bioquímica i Biologia Molecular, Fisiologia Humana, Genètica, Immunologia, Microbiologia i Neurociències.
  • Ciències Mèdiques i de la Salut: Ciències Clíniques, Epidemiologia, Medicina Forense, Medicina del treball, Medicina Interna, Ciències de la nutrició, Patologia, Farmacodinàmica, Farmacologia, Medicina Preventiva, Psiquiatria, Salut Pública, Cirurgia i Toxicologia.
    		•
     
    Borses de viatge
    Termini exhaurit
    DAAD - DEUTSCHER AKADEMISCHER AUSTAUSCH DIENST
     
    Termini exhaurit
    CENTRE FOR INTERNATIONAL MOBILITY
    The primary target group in the CIMO Fellowship programme are such Doctoral level students who will be doing their Doctorate (or Double Doctorate) at a Finnish university . Visiting Doctoral-level students and researchers who are doing their Doctorate degree at some foreign university can also be considered eligible, provided that the motivation letter of the hosting Finnish university department presents exceptionally good grounds for such an application.

    NB: the CIMO Fellowship is a "start-up" grant rather than a full degree scholarship, so if you for example receive a CIMO Fellowship for 12 months, after that period you should seek other sources of funding for the remaining period of your studies/research.
     
    Termini exhaurit
    FEBS - FEDERATION OF EUROPEAN BIOCHEMICAL SOCIETIES
     
    Termini exhaurit
    DAAD - DEUTSCHER AKADEMISCHER AUSTAUSCH DIENST
     
    Termini exhaurit
    CANON FOUNDATION IN EUROPE
    Annually, the Canon Foundation in Europe grants up to 15 Fellowships to highly qualified European and Japanese researchers. European Fellows are expected to pursue a period of research in Japan whereas Japanese Fellows are expected to do their research in Europe.
    We support all fields of research. There are no limitations or restrictions. Applicants do not have to be currently enrolled or employed at the time of applying.
     
    Premis
    Termini exhaurit
    COMISSIÓ EUROPEA
    The Science & PINS Prize for Neuromodulation is a highly competitive prize which honors scientists for their excellent contributions to neuromodulation research.
    The Prize is awarded annually to one young researcher for the most outstanding neuromodulation research conducted by him/her during the past three years.
     
    Termini exhaurit
    FUNDACION MAPFRE
    Reconeix una contribució rellevant realitzada per entitats o persones en la promoció de la salut i la millora de la qualitat de vida
     
    Termini exhaurit
    Universal Medica Events
     
    Recursos Humans
    Termini exhaurit
    EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL)
    As Europe’s only intergovernmental research organisation in the life sciences and as a leading laboratory in molecular biology, EMBL is dedicated to promoting excellence in the molecular life sciences throughout Europe. One of the best ways to achieve this goal is by inspiring and fostering talented young scientists to turn them into skilled and creative future leaders.
    The EMBL International PhD Programme provides comprehensive training that promotes scientific excellence, independence and creativity.
     
    Termini exhaurit
    Multiple Myeloma Research Foundation, Inc. (MMRF)
    The goal of the Research Fellow Award is to help support young investigators to begin their studies in the field of multiple myeloma while advancing the understanding of myeloma disease biology, treatment and drug resistance.
     
     
     
    Informació últil
     
     
     
    Banner-convocatories-tancament-02
    Projectes
    Termini exhaurit
    COMISSIÓ EUROPEA
    ERACoSysMed is the first Systems Medicine oriented ERA-NET under Horizon 2020. The 14 participating funding bodies agreed on a joint agenda to specifically support demonstrator projects that identify areas where a systems approach addresses a clinical question and provides solution strategies to clinical problems.
     
    Termini exhaurit
    COMISSIÓ EUROPEA
    ERA-CVD is a newly established European Research Area Network (ERA-Net) comprising 23 Partners from 18 countries/regions. The goal of ERA-CVD is to create a European Research Area in which cardiovascular research is conducted and funded across countries, allowing research groups to jointly work on specific problems, exchange ideas, and benefit from cross border expertise.
     
    Termini exhaurit
    COMISSIÓ EUROPEA
    ERA-NETs are projects funded by the European Commission in various research fields. Their goal is to create a European Research Area in which research is conducted and funded across countries, allowing research groups to jointly work on specific problems, exchange ideas, and benefit from cross border expertise.
     
    Termini exhaurit
    COMISSIÓ EUROPEA
    The EU Joint Programme on Neurodegenerative Disease Research (JPND) was established in order to better coordinate research efforts across countries and disciplines to more rapidly find causes, develop cures and identify better ways to care for people with neurodegenerative disease. The JPND Research Strategy, published in 2012, identified research priorities and provided a framework for future investment.
     
    Termini exhaurit
    COMISSIÓ EUROPEA
    EU-LAC Health (Defining a Roadmap for Cooperative Health research between the EU and Latin America-Caribbean countries: a Policy Oriented Approach) is a project co-funded by the EU (European Union) through the 7th Framework Programme. Its main goal is the definition of a detailed roadmap to guide policy-makers and other stakeholders on future actions to support cooperative health research between European (EU) and Latin America and Caribbean (LAC) countries.
     
    Termini exhaurit
    LADY TATA MEMORIAL TRUST
     
    Termini exhaurit
    AA - ALZHEIMER ASSOCIATION
    The Alzheimer's Association International Research Grant Program funds investigations that advance our understanding of Alzheimer's disease, help identify new treatment strategies, provide information to improve care for people with dementia, and further our knowledge of brain health and disease prevention. Our awards support investigators at every professional stage.
     
    Termini exhaurit
    ASOCIACIÓN ESPAÑOLA DE PEDIATRÍA
    El projecte d'investigació haurà de versar sobre un tema lliure de Pediatria valorant-se especialment els projectes multicèntrics i/o internivells assistencials.
     
    Termini exhaurit
    FUNDACIO LA CAIXA
    L'objecte de la present convocatòria és la tutoria de projectes de valorització dels actius resultants de la investigació, per al seu trasllat al mercat, ja sigui com un spin-off o com un acord de transferència, que requereixen la validació i desenvolupament de la seva proposta de generació de valor.
    Més específicament, el programa donarà suport a projectes de les àrees de la Vida, Medicina i Ciències de la Salut proposades pels centres, basats en actius per als quals s'ha sol·licitat o serà sol·licitada una patent o model d'utilitat, i destinats a afegir valor per a la seva transferència al mercat.
    Dins les àrees de la Vida, Medicina i Ciències de la Salut, es tindran en compte els projectes dels següents camps:
  • Ciències de la Vida: Biomatemàtica, Biologia Cel·lular, Biologia Humana, Bioquímica i Biologia Molecular, Fisiologia Humana, Genètica, Immunologia, Microbiologia i Neurociències.
  • Ciències Mèdiques i de la Salut: Ciències Clíniques, Epidemiologia, Medicina Forense, Medicina del treball, Medicina Interna, Ciències de la nutrició, Patologia, Farmacodinàmica, Farmacologia, Medicina Preventiva, Psiquiatria, Salut Pública, Cirurgia i Toxicologia.
    		•
     
    Termini exhaurit
    FUNDACIÓN MUTUA MADRILEÑA
    Mitjançant aquesta XII Convocatòria es concediran un màxim de 15 ajudes a equips d'investigadors amb reconeguda experiència, que treballin en els següents camps d'investigació:
  • Oncologia. Específicament en càncer ginecològic (cérvix, ovaris i úter).
  • Trasplantament. Exclusivament en estratègies de millora en l'obtenció i utilització d'òrgans per a trasplantaments
  • Traumatologia i seqüeles, incloses les neurològiques derivades d'un traumatisme. .
  • Malalties rares. Limitades a les quals es manifesten en la infància.
    Els projectes que es presentin a aquesta convocatòria haurien de ser exclusivament treballs d'investigació clínica
    •  
    Termini exhaurit
    LADY TATA MEMORIAL TRUST
     
    Termini exhaurit
    PROSTATE CANCER FOUNDATION
    The Prostate Cancer Foundation (www.pcf.org) champions investment in human capital to fast-forward solutions for prostate cancer with the ultimate goal of ending death and suffering from metastatic prostate cancer.
    Research proposals submitted in consideration for the Young Investigator Award should, if successful, provide high impact to the field. “Small-step” or incremental proposals are usually non-competitive. Highly innovative basic science programs will be carefully considered, but priority will be given to “bench to bedside” translational research proposals with the potential to deliver near term benefit to patients.
     
    Termini exhaurit
    BRAIN & BEHAVIOR RESEARCH FOUNDATION
    The Brain & Behavior Research Foundation is the largest philanthropic organization dedicated to research across all brain and behavior disorders (not disease specific). Recipients of NARSAD Grants represent an extraordinary variety of disciplines. Research has included (but is not limited to) studies in: genetics, neurobiology, molecular biology, imaging, neurochemical studies, neurophysiology, electrophysiology, clinical psychopharmacology, descriptive clinical studies, epidemiological research, treatment modalities, cognition studies, and outcome and prevention research.
     
    Termini exhaurit
    FJL - FONDATION JEROME LEJEUNE
    The main target of the Fondation Jerome Lejeune, a non profit foundation, is research into genetic diseases with intellectual disability.
     
    Termini exhaurit
    LEUKEMIA RESEARCH FOUNDATION
    The Leukemia Research Foundation is dedicated to conquering all blood cancers by funding research into their causes and cures, and enriching the quality of life of those touched by these diseases.
    The Leukemia Research Foundation exclusively funds New Investigator grants only.
     
    Termini exhaurit
    EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
     
    Termini exhaurit
    EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
     
    Borses de viatge
    Termini exhaurit
    FUNDACIÓ PRIVADA DANIEL BRAVO ANDREU
    L'objectiu principal es generar una xarxa de col·laboració entre grups de recerca biomèdica d'excel·lència a Catalunya i l'estranger. Es concediran tres beques per a estades d'un a nou mesos en projectes punters de centres de recerca de prestigi nordamericans o europeus en les àrees següents:
    • Recerca cardiovascular pediàtrica (infants i adolescents)
    • Recerca cardiovascular (adults)
     
    Termini exhaurit
    UICC-GLOBAL CANCER CONTROL
    Union for International Cancer Control (UICC) is a membership organisation that exists to help the global health community accelerate the fight against cancer.
    Founded in 1933 and based in Geneva, UICC’s growing membership of over 900 organisations across 155 countries, features the world’s major cancer societies, ministries of health, research institutes and patient groups. Together with its members, key partners, the World Health Organization, World Economic Forum and others, UICC is tackling the growing cancer crisis on a global scale.
     
    Termini exhaurit
    FUNDACIÓN ALICIA KOPLOWITZ
    Convocar 8 beques per a realitzar estades, d'entre 6 i 12 mesos, per a ampliar la formació acadèmica, clínica, metodològica o col·laborar en projectes d'investigació en centres estrangers de prestigi en Psiquiatria Infanto-Juvenil i en Neurociències en el nen i adolescent.
     
    Termini exhaurit
    FUNDACIO LA CAIXA
    Concessió de 20 beques per realitzar estudis oficials de doctorat que culminin amb la lectura de la tesi doctoral en una universitat espanyola.
    La convocatòria comprèn totes les àrees del coneixement.
     
    Termini exhaurit
    UICC-GLOBAL CANCER CONTROL
     
    Premis
    Termini exhaurit
    COMISSIÓ EUROPEA
    The Science & PINS Prize for Neuromodulation is a highly competitive prize which honors scientists for their excellent contributions to neuromodulation research.
    The Prize is awarded annually to one young researcher for the most outstanding neuromodulation research conducted by him/her during the past three years.
     
    Termini exhaurit
    FUNDACION MAPFRE
    Reconeix una contribució rellevant realitzada per entitats o persones en la promoció de la salut i la millora de la qualitat de vida
     
    Termini exhaurit
    FUNDACIÓ DR. ANTONI ESTEVE
    La Fundació Dr. Antoni Esteve convoca la quinzena edició del seu Premi de Recerca, que aquest any busca el millor treball de Farmacologia publicat per un autor espanyol en els darrers tres anys. S’atorgarà al millor treball de recerca farmacològica, en qualsevol de les seves vessants (disseny, síntesi, desenvolupament galènic, avaluació clínica o de laboratori, ús, etcètera) publicat en qualsevol revista científica durant els anys 2014, 2015 i 2016.
     
    Termini exhaurit
    FUNDACIÓN CASER
    Per vuitè any consecutiu la Fundació Caser obre la convocatòria dels seus premis Dependència i Societat , amb l'objectiu de reconèixer les millors iniciatives en aquesta matèria, podran presentar-se les candidatures a qualsevol de les tres categories que integren aquests guardons a:
  • Excel·lència en Dependència
  • R+D en Dependència
  • Comunicació en Dependència
    		•
     
    Termini exhaurit
    EUROPEAN RESPIRATORY SOCIETY
    ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
     
    Termini exhaurit
    EUROPEAN RESPIRATORY SOCIETY
    ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
     
    Termini exhaurit
    EUROPEAN RESPIRATORY SOCIETY
    ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
     
    Termini exhaurit
    FUNDACION PREMIOS REY JAIME I
    El premi es concedirà a aquella persona que la seva tasca hagi estat altament significativa.
    Els candidats podran ser proposats per investigadors, universitats, acadèmies, col·legis professionals, hospitals, empreses, fundacions i altres.
     
    Termini exhaurit
    LABORATORIOS GRIFOLS S.A.
    The Martín Villar Haemostasis Awards aim to support scientific excellence and innovation, and to engage both physicians and scientists who are early in their careers in investigating hemostasis and blood coagulation disorders.
    The 2017 edition of the Martin Villar Awards introduces a new concept for the Awards by providing one grant for a project in Clinical Research and one grant for a project in Basic Research.
     
    Recursos Humans
    Termini exhaurit
    FUNDACIÓ BANC DE SABADELL
    La Fundació Banc de Sabadell convoca 15 ajudes a la investigació científica per a aspirants predoctorals de nacionalitat espanyola, que estiguin en procés de realització de la tesi doctoral en qualsevol universitat espanyola o estrangera, destinades a la promoció i desenvolupament de treballs científics o estades en universitats o altres centres de recerca espanyols o estrangers, preferentment en camps del coneixement en ciencias socials i humanitats.
     
    Termini exhaurit
    FUNDACIÓN ALICIA KOPLOWITZ
     
    Termini exhaurit
    EUROPEAN HEMATOLOGY ASSOCIATION
    The EHA-JSH Collaborative Exchange Program is intended to provide European and Japanese research institutes the opportunity to exchange scientists and clinical researchers reciprocally for a short period.
     
     
     
     
    Articles
     
    Pedro-Botet J*, Climent E. Un resplandor en la prevención secundaria de la enfermedad cardiovascular. Clin Invest Arterioscl 2017; 29(1): 20-21.
     
    Roquer González J*, Vivanco R, Ois A, Rodríguez Campello A, Cuadrado E, Giralt E, Gómez-González A, Soriano Tàrrga C, Jiménez Conde J. Antithrombotic pretreatment increases very-early mortality in primary intracerebral hemorrhage. Neurology 2017; 88(9): 885-891.
     
    Temam S*, Burte E, Adam M, Antó JM, Basagaña X, Bousquet J, Carsin AE, Galobardes B, Keidel D, Künzli N, Le Moual N, Sanchez M, Sunyer J, Bono R, Brunekreef B, Heinrich J, de Hoogh K, Jarvis D, Marcon A, Modig L, Nadif R, Nieuwenhuijsen M, Pin I, Siroux V, Stempfelet M, Tsai MY, Probst-Hensch N, Jacquemin B. Socioeconomic position and outdoor nitrogen dioxide (NO2) exposure in Western Europe: A multi-city analysis. Environ Int 2017; 101: 117-124.
     
    Cano M, Martínez-Zalacaín I, Bernabéu-Sanz Á, Contreras-Rodríguez O, Hernández-Ribas R, Via E, de Arriba-Arnau A, Gálvez V, Urretavizcaya M, Pujol J, Menchón JM*, Cardoner N*, Soriano-Mas C. Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study. Transl Psychiatry 2017; 7(2): e1023.
     
    Rivas I*, Mazaheri M, Viana M, Moreno T, Clifford S, He C, Bischof OF, Martins V, Reche C, Alastuey A, Alvarez-Pedrerol M, Sunyer J, Morawska L, Querol X. Identification of technical problems affecting performance of DustTrak DRX aerosol monitors. Sci Total Environ 2017; 585-585: 849-855.
     
    Yu E, Ruiz Canela M, Guasch-Ferré M, Zheng Y, Toledo E, Clish CB, Salas Salvadó J, Liang L, Wang DD, Corella D, Fitó Colomer M, Gómez Gracia E, Lapetra J, Estruch Riba R, Ros E, Cofán M, Arós F, Romaguera D, Serra Majem L, Sorlí J, Hu FB, Martinez-Gonzalez MA*. Increases in Plasma Tryptophan Are Inversely Associated with Incident Cardiovascular Disease in the Prevención con Dieta Mediterránea (PREDIMED) Study. J Nutr 2017; 147(3): 314-322.
     
    Held U*, Kessels A, Garcia-Aymerich J, Basagaña X, ter Riet G, Moons KG, Puhan MA, International COPD Cohorts Collaboration Working Group. The authors reply. Am J Epidemiol 2017; 185(5): 406.
     
    Navarro J, Gozalbo-López B, Méndez AC, Dantzer F, Schreiber V, Martínez C, Arana DM, Farrés J, Revilla-Nuin B, Bueno MF, Ampurdanés C, Galindo-Campos MA, Knobel PA, Segura-Bayona S, Martin-Caballero J, Stracker TH, Aparicio P, Del Val M*, Yelamos J*. PARP-1/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas. Sci Rep 2017; 7: 41962.
     
    Bernardo M*, Bioque M, Cabrera B, Lobo A, González Pinto A, Pina L, Corripio I, Sanjuán J, Mané A, Castro-Fornieles J, Vieta E, Arango C, Mezquida G, Gassó P, Parellada M, Saiz-Ruiz J, Cuesta MJ, Mas S, PEPs GROUP. Modelling gene-environment interaction in first episodes of psychosis. Schizophr Res 2017; 189: 181-189.
     
    Ponomarenko J*, Garrido R, Guigó R. Ten Simple Rules on How to Organize a Scientific Retreat. PLoS Comput Biol 2017; 13(2): e1005344.
     
    Chacón-Cabrera A, Mateu-Jiménez M, Langohr K, Fermoselle C, García-Arumí E, Andreu AL, Yelamos J, Barreiro E*. Role of Parp Activity in Lung Cancer-induced Cachexia: Effects on Muscle Oxidative Stress, Proteolysis, Anabolic Markers and Phenotype. J Cell Physiol 2017; 232(12): 3744-3761.
     
    Álvarez-Lerma F, Marin J*, Vilà C, Masclans JR, Loeches IM, Barbadillo S, González de Molina FJ, Rodríguez A, H1N1 GETGAG/SEMICYUC Study Group. Characteristics of patients with hospital-acquired influenza A (H1N1)pdm09 virus admitted to the intensive care unit. J Hosp Infect 2017; 95(2): 200-206.
     
    Sanvisens A, Zuluaga P, Rivas I, Rubio G, Gual A, Torrens M, Short A, Álvarez FJ, Tor J, Farré M, Rodríguez de Fonseca F, Muga R. Pacientes con trastorno por uso de alcohol: resultados iniciales de un registro multicéntrico en la Red de Trastornos Adictivos-RTA. Estudio CohRTA. Adicciones 2018; 30(4): 292-300.
     
    Rossi P, Blay E, Costela V, Torrens M*. Política de drogas ilegales en España: la opinión de los profesionales del ámbito sanitario y del legal. Adicciones 2018; 30(1): 33-40.
     
    Ruhwald M*, Aggerbeck H, Gallardo RV, Hoff ST, Villate JI, Borregaard B, Martinez JA, Kromann I, Penas A, Anibarro LL, de Souza-Galvao ML, Sánchez F, Rodrigo-Pendás JÁ, Noguera-Julian A, Martínez-Lacasa X, Tuñez MV, Fernández VL, Millet JP, Moreno A, Cobos N, Miró JM, Roldan L, Orcau A, Andersen P, Caylá JA, TESEC Working Group. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. Lancet Resp. Med. 2017; 5(4): 259-268.
     
    García-Marchena N, Araos PF, Barrios V, Sánchez-Marín L, Chowen JA, Pedraz M, Castilla-Ortega E, Romero-Sanchiz P, Ponce G, Gavito AL, Decara J, Silva D, Torrens M, Argente J, Rubio G, Serrano A*, Rodriguez-de Fonseca F*, Pavón FJ*. Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric Comorbidity. Front Psychiatry 2017; 7: 214.
     
    León-Gómez BB, Colell E, Villalbí JR, Barrio G, Domingo-Salvany A*. Impact of smoke-free regulations on smoking prevalence trends in Spain. Eur J Public Health 2017; 27(1): 123-128.
     
    Fernandez-Garcia JC, Alcaide J, Santiago-Fernandez C, Roca-Rodriguez MM, Aguera Z, Baños R, Botella C, de la Torre R, Fernandez-Real JM, Fruhbeck G, Gomez-Ambrosi J, Jimenez-Murcia S, Menchon JM, Casanueva FF, Fernandez-Aranda F, Tinahones FJ*, Garrido-Sanchez L. An increase in visceral fat is associated with a decrease in the taste and olfactory capacity. PLoS ONE 2017; 12(2): e0171204.
     
    Arpón A, Riezu-Boj JI, Milagro FI, Razquin C, Martínez-González MA, Corella D, Estruch Riba R, Casas R, Fitó Colomer M, Ros E, Salas Salvadó J, Martínez J.A*. Adherence to Mediterranean diet is associated with methylation changes in inflammation-related genes in peripheral blood cells. J Physiol Biochem 2017; 73(3): 445-455.
     
    Avellaneda-Gómez C, Rodríguez Campello A*, Giralt E, Gómez-González A, Serra M, de Ceballos P, Zabalza A, Roquer González J, Cuadrado E, Ois A, Jiménez Conde J. Estudio descriptivo de los stroke mimics después de un estudio neurovascular completo. Neurología (Barc) 2019; 34(1): 7-13.
     
    Bisbe E*, Basora M, Colomina MJ, Spanish Best Practice in Peri-operative Anaemia Optimisation Panel (...,Moltó L,...). Peri-operative treatment of anaemia in major orthopaedic surgery: a practical approach from Spain. Blood Transfus 2017; 15(4): 296-306.
     
    Fernández-Carrillo C, Lens S, Llop E, Pascasio JM, Crespo J, Arenas J, Fernández I, Baliellas C, Carrion JA, de la Mata M, Buti M, Castells L, Albillos A, Romero M, Turnes J, Pons C, Moreno-Planas JM, Moreno-Palomares JJ, Fernández-Rodriguez C, García-Samaniego J, Prieto M, Fernández-Bermejo M, Salmerón J, Badia E, Salcedo M, Herrero JI, Granados R, Blé M, Mariño Z, Calleja JL*. Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry. Hepatology 2017; 65(6): 1810-1822.
     
    Perearnau A, Orlando S, Islam AB, Gallastegui E, Martínez J, Jordan A, Bigas A, Aligué R, Pujol MJ, Bachs O*. p27Kip1, PCAF and PAX5 cooperate in the transcriptional regulation of specific target genes. Nucleic Acids Res 2017; 45(9): 5086-5099.
     
    Brammeld J, Petljak M, Martincorena I, Williams SP, Alonso LG, Dalmases A, Bellosillo B, Robles-Espinoza CD, Price S, Barthorpe S, Tarpey P, Alifrangis C, Bignell G, Vidal J, Young J, Stebbings L, Beal K, Stratton MR, Saez-Rodriguez J, Garnett M, Montagut C, Iorio F, McDermott U*. Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations. Genome Res 2017; 27(4): 613-625.
     
    Ribas N*, Garcia C, Meroño O, Recasens L, Pérez-Fernández S, Bazan V, Salvatella N, Martí Almor J, Bruguera J, Elosua R. Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion. BMC Cardiovasc Disord 2017; 17: 54.
     
    Roca A*, Vila JS, Massa J, Timoneda Paz, Peñas M, Herrero FJ, Sánchez-Jiménez J, Ballester A. Prevalence of illicit drug use at the end of pregnancy: a cross-sectional study at the time of birth. Minerva Pediatr 2020; 72(1): 37-44.
     
     
    Institut Hospital del Mar d'Investigacions Mèdiques
    Tel: 93 316 04 00
    Doctor Aiguader, 88
    08003 Barcelona
    Seguiu-nos a:
    Twitter
    Youtube
    En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
    Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).